These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 33783826)
21. Estimating the course of the COVID-19 pandemic in Germany via spline-based hierarchical modelling of death counts. Wistuba T; Mayr A; Staerk C Sci Rep; 2022 Jun; 12(1):9784. PubMed ID: 35697761 [TBL] [Abstract][Full Text] [Related]
22. Web-based internet searches for digital health products in the United Kingdom before and during the COVID-19 pandemic: a time-series analysis using app libraries from the Organisation for the Review of Care and Health Applications (ORCHA). Leigh S; Daly R; Stevens S; Lapajne L; Clayton C; Andrews T; Ashall-Payne L BMJ Open; 2021 Oct; 11(10):e053891. PubMed ID: 34635531 [TBL] [Abstract][Full Text] [Related]
23. Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia. Blakely T; Thompson J; Bablani L; Andersen P; Ait Ouakrim D; Carvalho N; Abraham P; Boujaoude MA; Katar A; Akpan E; Wilson N; Stevenson M JAMA Health Forum; 2021 Jul; 2(7):e211749. PubMed ID: 35977202 [TBL] [Abstract][Full Text] [Related]
25. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
26. Perceptions of Covid-19 lockdowns and related public health measures in Austria: a longitudinal online survey. Łaszewska A; Helter T; Simon J BMC Public Health; 2021 Aug; 21(1):1502. PubMed ID: 34344343 [TBL] [Abstract][Full Text] [Related]
27. Rate of COVID-19 infection and 30 day mortality between blue and green (dedicated COVID-19 safe) pathways: Results from phase 1 and 2 of the UK foot and ankle COVID-19 national (UK-FAlCoN) audit. Malhotra K; Mangwani J; Houchen-Wollof L; Mason LW; Foot Ankle Surg; 2022 Oct; 28(7):1055-1063. PubMed ID: 35256273 [TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 pandemic and Construction Industry: insights from Italian data. Riccò M Acta Biomed; 2022 Jul; 93(3):e2022233. PubMed ID: 35775779 [TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic. Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480 [TBL] [Abstract][Full Text] [Related]
30. Estimates of the ongoing need for social distancing and control measures post-"lockdown" from trajectories of COVID-19 cases and mortality. Lonergan M; Chalmers JD Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32482785 [TBL] [Abstract][Full Text] [Related]
31. The impact of the COVID-19 pandemic on the number of presentations of penetrating injuries to a UK major trauma centre. Hickland MM; Massouh P; Sutthakorn RE; Greenslade C; Jennings C; Cantle F; Bew D J Public Health (Oxf); 2022 Mar; 44(1):e126-e132. PubMed ID: 34428291 [TBL] [Abstract][Full Text] [Related]
32. Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling. Mishra S; Scott JA; Laydon DJ; Flaxman S; Gandy A; Mellan TA; Unwin HJT; Vollmer M; Coupland H; Ratmann O; Monod M; Zhu HH; Cori A; Gaythorpe KAM; Whittles LK; Whittaker C; Donnelly CA; Ferguson NM; Bhatt S Sci Rep; 2021 Aug; 11(1):16342. PubMed ID: 34381102 [TBL] [Abstract][Full Text] [Related]
33. Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study. Tran Kiem C; Crépey P; Bosetti P; Levy Bruhl D; Yazdanpanah Y; Salje H; Boëlle PY; Cauchemez S Euro Surveill; 2021 Jun; 26(22):. PubMed ID: 34085634 [TBL] [Abstract][Full Text] [Related]
34. Coping Using Sex During the Coronavirus Disease 2019 (COVID-19) Outbreak in the United Kingdom. Gillespie SM; Jones A; Uzieblo K; Garofalo C; Robinson E J Sex Med; 2021 Jan; 18(1):50-62. PubMed ID: 33309464 [TBL] [Abstract][Full Text] [Related]
35. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study. Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A; Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572 [TBL] [Abstract][Full Text] [Related]
36. The effect of lockdown on the COVID-19 epidemic in Brazil: evidence from an interrupted time series design. Silva L; Figueiredo Filho D; Fernandes A Cad Saude Publica; 2020; 36(10):e00213920. PubMed ID: 33084836 [TBL] [Abstract][Full Text] [Related]
37. Transmission dynamics of the COVID-19 epidemic in England. Liu Y; Tang JW; Lam TTY Int J Infect Dis; 2021 Mar; 104():132-138. PubMed ID: 33359440 [TBL] [Abstract][Full Text] [Related]
38. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. COVID-19 Forecasting Team Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376 [TBL] [Abstract][Full Text] [Related]
39. Short-term and long-term health impacts of air pollution reductions from COVID-19 lockdowns in China and Europe: a modelling study. Giani P; Castruccio S; Anav A; Howard D; Hu W; Crippa P Lancet Planet Health; 2020 Oct; 4(10):e474-e482. PubMed ID: 32976757 [TBL] [Abstract][Full Text] [Related]
40. The impact of multi-level interventions on the second-wave SARS-CoV-2 transmission in China. He Y; Chen Y; Yang L; Zhou Y; Ye R; Wang X PLoS One; 2022; 17(9):e0274590. PubMed ID: 36112630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]